47 results
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
17 Jul 23
Report of Foreign Private Issuer
7:11am
acknowledgment in the scientific and medical community, as evidenced by the numerous peer-reviewed publications and conferences in which it has been published
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
25 Oct 22
Report of Foreign Private Issuer
7:08am
look forward to sharing our findings on this case with the community of hepatologists at The Liver Meeting in order to advance scientific knowledge
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
9 Jun 22
Can-Fite Announces Publication of Clinical Study Data for Piclidenoson and Namodenoson in Scientific Journal
7:03am
efficacy and safety data in over 1,500 patients, and three indications in Phase II and III studies.
In the scientific community, A3AR is well
6-K
EX-99.1
3r6v36ho 89seyoj9
5 Mar 21
Report of Foreign Private Issuer
7:17am
6-K
EX-99.1
3g2mm1gz4det
24 Nov 20
Report of Foreign Private
7:07am
6-K
EX-99.1
k5w0cs82rb5
30 Sep 20
Principal Investigator Prof. Rifaat Safadi to present Namodenoson’s Phase II results at highly prestigious scientific conference for liver diseases
7:12am
424B3
ix32equ6hr8r1cd
1 Jun 20
Prospectus supplement
7:23am
6-K
EX-99.4
4s2dj7oi 35dqtqxjed
1 Jun 20
Report of Foreign Private Issuer
7:06am
6-K
EX-99.1
fqa c7wq73obog8
13 Feb 20
Notice of Special General Meeting of Shareholders
4:30pm
424B4
od1kbvfkcc6t2q2eb87
12 Feb 20
Prospectus supplement with pricing info
6:46am
F-1/A
7xkl1s50beezxu
3 Feb 20
Registration statement (foreign) (amended)
5:31pm
F-1
zrnfsynt5z
24 Jan 20
Registration statement (foreign)
4:40pm
6-K
EX-99.1
pygt7zj31frs hutcr
16 Jan 20
Can-Fite and Univo Pharmaceuticals Collaboration Result in Discovery and Applied Patent for Cannabinoid Formulations with Broad Therapeutic Effects
7:09am
6-K
EX-99.1
dof jj5ve
9 Jan 20
Notice of Special General Meeting of Shareholders
4:41pm
6-K
EX-99.1
3tg4nse 45d4
6 Nov 19
2019 Annual General Meeting of Shareholders
4:42pm